MCAM and lung cancer: Echoing flow cytometry results, binding of pemetrexed to CD146 shRNA yielded the highest levels of cleaved PARP, cleaved caspase 3 and BAX, indicating that CD146 is resistant to pemetrexed mediated apoptosis in lung cancer brain metastases.